Heart Complication Risk Higher After COVID-19 Infection Than Vaccination, Study Finds

Looking at electronic health record data from more than four million children and adults who received mRNA COVID-19 vaccines and more than 800,000 patients who tested positive for COVID-19, researchers found that the incidence of myocarditis or pericarditis was significantly higher among adolescents and young adults who tested positive for COVID-19 compared with same-aged individuals who received a vaccine.

These results will enable a better understanding about the comparative risks of heart complications following COVID-19 infection and vaccination. The US Centers for Disease Control and Prevention-led study is the latest example of how PCORnet®, the National Patient-Centered Clinical Research Network—funded by PCORI—is facilitating robust COVID-19 research.

View the Report

Study Using PCORnet® Suggests Disparities in Receipt of COVID-19 Medications

Underscoring the health inequities that have characterized the COVID-19 pandemic, an analysis of health data accessed via a PCORI-funded network suggests that monoclonal antibodies, medications highly effective at lessening the severity of COVID-19, are underused among individuals who identify as Black, Asian, or Hispanic. This apparent underuse occurred even though these groups are experiencing higher rates of infection, hospitalization, and death.

The US Centers for Disease Control and Prevention-led study analyzed patient data from 41 healthcare systems participating in PCORnet®, the National Patient-Centered Clinical Research Network, funded by PCORI to conduct research more efficiently.

View the Report

Changes to Telehealth Policy, Delivery, and Outcomes in Response to COVID-19

During the COVID-19 pandemic, there has been a rapid shift toward virtual visits and digital tools to monitor and help patients manage their health care. PCORI solicited a landscape review to summarize how reimbursement, regulatory, and delivery systems have changed for telehealth during the coronavirus pandemic. The goal was to use this information, in combination with conversations with key stakeholders, to better understand how changes in the delivery system during COVID-19 might alter PCORI’s strategic focus on future investment in telehealth research. This report provides a rich summary of changes under the pandemic and highlights some areas in telehealth where additional research may be valuable.

View the Report

PCORnet Facilitates New Research on Drugs' Effectiveness for COVID-19

ACTIV-6 — a new clinical trial platform unveiled by the National Institutes of Health — will use PCORnet®, the National Patient-Centered Clinical Research Network, to help determine if some prescription and over-the-counter medications can effectively treat COVID-19 in non-hospitalized patients. While some drugs approved for other conditions have been studied to treat mild to moderate cases of COVID-19, ACTIV-6 aims to provide definitive evidence for patients and clinicians seeking to manage the disease and avoid hospitalization.

Learn More


PCORI-Funded Research Studies and Engagement Awards

Closed PCORI Funding Announcements

Messages from PCORI's Leadership

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.

Subscribe to PCORI Emails


Hand pointing to email icon